Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas

被引:34
作者
Hegardt, P [1 ]
Widegren, B [1 ]
Sjögren, HO [1 ]
机构
[1] Dept Cell & Mol Biol, Sect Tumor Immunol, S-22362 Lund, Sweden
基金
英国医学研究理事会;
关键词
D O I
10.1006/cimm.2000.1625
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of nitric oxide (NO) and adherent spleen cells in systemic immunosuppression developing in animals carrying malignant glioma isografts was analyzed. Rats harboring a subcutaneous glioma isograft for 3 weeks were immunized with glioma cells genetically engineered to express IFN-gamma. One week later spleen cells were tested for immune responsiveness in vitro. A decreased cytotoxic activity of NKcells and T-cells compared to tumor-free animals immunized in parallel was shown. Spleen cell proliferative responses to tumor cells, SEA, and anti-CD3 were all significantly suppressed, as was the production of IFN-gamma and IL-10, Plastic adherent spleen cells from tumor-bearing rats suppressed the SEA-induced proliferative response and the production of IFN-gamma and IL-10 by nonadherent spleen cells from tumor-free rats. A major part of this suppression appears to be dependent on the production of NO because suppression was efficiently counteracted in vitro by the NO-synthase inhibitor N-nitro-L-arginine methyl ester. Moreover, a significantly increased level of nitrite in culture supernatants correlated with the observed suppression. We conclude that the systemic immunosuppression associated with growing gliomas is in part mediated by mechanisms dependent on NO overproduction in adherent spleen cells. (C) 2000 Academie Press.
引用
收藏
页码:116 / 127
页数:12
相关论文
共 49 条
[1]  
ALLEVA DG, 1994, J IMMUNOL, V153, P1674
[2]   The expression of nitric oxide synthases in human brain tumours and peritumoral areas [J].
Bakshi, A ;
Nag, TC ;
Wadhwa, S ;
Mahapatra, AK ;
Sarkar, C .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) :196-203
[3]  
BODMER S, 1989, J IMMUNOL, V143, P3222
[4]  
Brito C, 1999, J IMMUNOL, V162, P3356
[5]  
Correa MR, 1997, J IMMUNOL, V158, P5292
[6]   Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE [J].
Cowden, WB ;
Cullen, FA ;
Staykova, MA ;
Willenborg, DO .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) :1-8
[7]  
Crow JP, 1996, METHOD ENZYMOL, V269, P185
[8]   INTERLEUKIN-10 (IL-10) INHIBITS THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY INTERFERON-GAMMA IN MURINE MACROPHAGES [J].
CUNHA, FQ ;
MONCADA, S ;
LIEW, FY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1155-1159
[9]   INABILITY OF MITOGEN-ACTIVATED LYMPHOCYTES OBTAINED FROM PATIENTS WITH MALIGNANT PRIMARY INTRACRANIAL TUMORS TO EXPRESS HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS [J].
ELLIOTT, LH ;
BROOKS, WH ;
ROSZMAN, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :80-86
[10]   Tumor-induced suppression of antitumor reactivity and depression of TCR zeta expression in tumor-draining lymph node lymphocytes: Possible relationship to the Th2 pathway [J].
Fu, EJ ;
Arca, MJ ;
Hain, JM ;
Krinock, R ;
Rado, J ;
Cameron, MJ ;
Chang, AE ;
Sondak, VK .
JOURNAL OF IMMUNOTHERAPY, 1997, 20 (02) :111-122